These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1249398)

  • 1. Paying the pharmacist a fee for detecting adverse drug reactions.
    Spaulding G; Hefner DL; Campbell RK
    J Am Pharm Assoc; 1976 Feb; 16(2):86-9. PubMed ID: 1249398
    [No Abstract]   [Full Text] [Related]  

  • 2. A critical review of the remuneration systems for pharmacists.
    Huttin C
    Health Policy; 1996 Apr; 36(1):53-68. PubMed ID: 10157820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Judicial views of the pharmacist's professional status.
    Fink JL
    Drug Intell Clin Pharm; 1979 Jan; 13(1):30-6. PubMed ID: 10240008
    [No Abstract]   [Full Text] [Related]  

  • 5. Rx fee in Utah rises if drug quantity extends beyond 30 days.
    Pharm Times; 1983 Sep; 49(9):32-3. PubMed ID: 10262970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the Effects of Pharmacist Intervention for Adverse Drug Reaction Detection and Exacerbation Avoidance].
    Imaura M; Yamaya T; Uehara N; Mano N; Nagase S; Kimura K; Kanno H; Yamada Y
    Yakugaku Zasshi; 2017; 137(6):767-774. PubMed ID: 28566582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacists contribute to the safety of medicines].
    Nishihara S
    Yakugaku Zasshi; 2011; 131(6):865-9. PubMed ID: 21628969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.
    Murphy AL; MacKinnon NJ; Flanagan PS; Bowles SK; Sketris IS
    Ann Pharmacother; 2005 Apr; 39(4):655-61. PubMed ID: 15728330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Documenting outpatient problem intervention activities of pharmacists in an HMO.
    Christensen DB; Campbell WH; Madsen S; Hartzema AG; Nudelman PM
    Med Care; 1981 Jan; 19(1):104-17. PubMed ID: 7464303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview.
    Acheampong F; Anto BP
    BMC Health Serv Res; 2015 Sep; 15():361. PubMed ID: 26345278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: II. Therapeutic category analysis, over-the-counter drug usage, and drug interactions.
    Norwood GJ; Helling DK; Burmeister LF; Jones ME; Yesalis CE; Fisher WP; Lipson DP
    Drug Intell Clin Pharm; 1981 Sep; 15(9):656-64. PubMed ID: 7274057
    [No Abstract]   [Full Text] [Related]  

  • 12. Considerations in establishing fees for home-care pharmaceutical services.
    Mirtallo JM
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S15-7. PubMed ID: 2672803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: I. Prescription quantity and dose analysis.
    Helling DK; Yesalis CE; Norwood GJ; Burmeister LF; Lipson DP; Fisher WP; Jones ME
    Drug Intell Clin Pharm; 1981; 15(7-8):581-9. PubMed ID: 7018872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug related problems in Belgian community pharmacies].
    Huysmans K; De Wulf I; Foulon V; De Loof H; Steurbaut S; Boussery K; De Vriese C; Lacour V; Van Hees T; De Meyer GR
    J Pharm Belg; 2014 Mar; (1):4-15. PubMed ID: 24804389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
    Alston G; Hanrahan C
    Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Joint responsability of physician and pharmacist for mistakes in the writing of a prescription].
    Kornprobst L
    Presse Med (1893); 1970 Nov; 78(47):2087-9. PubMed ID: 5483202
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationships among prescription payment methods and interactions between community pharmacists and prescribers.
    Raisch DW
    Ann Pharmacother; 1992; 26(7-8):902-6. PubMed ID: 1504395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADVERSE DRUG REACTIONS: FACTORS AND ROLE OF PHARMACIST IN THEIR PREVENTION.
    Bushra R; Baloch SA; Jabeen A; Bano N; Aslam N
    J Ayub Med Coll Abbottabad; 2015; 27(3):702-6. PubMed ID: 26721044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the pilot program on the real-time drug utilization review system in South Korea.
    Heo JH; Suh DC; Kim S; Lee EK
    Int J Med Inform; 2013 Oct; 82(10):987-95. PubMed ID: 23910897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.